Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis
<p>Abstract</p> <p>Background</p> <p>It is known that amyloid-β peptide (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). Interaction between Aβ and the receptor for advanced glycation end products (RAGE) has been implicated in neuronal deg...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-09-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1741-7015/10/105 |
| _version_ | 1811311171843653632 |
|---|---|
| author | Liu Rui Wu Cai-xia Zhou Dan Yang Fan Tian Shuo Zhang Li Zhang Tian-tai Du Guan-hua |
| author_facet | Liu Rui Wu Cai-xia Zhou Dan Yang Fan Tian Shuo Zhang Li Zhang Tian-tai Du Guan-hua |
| author_sort | Liu Rui |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>It is known that amyloid-β peptide (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). Interaction between Aβ and the receptor for advanced glycation end products (RAGE) has been implicated in neuronal degeneration associated with this disease. Pinocembrin, a flavonoid abundant in propolis, has been reported to possess numerous biological activities beneficial to health. Our previous studies have demonstrated that pinocembrin has neuroprotective effects on ischemic and vascular dementia in animal models. It has been approved by the State Food and Drug Administration of China for clinical use in stroke patients. Against this background, we investigated the effects of pinocembrin on cognitive function and neuronal protection against Aβ-induced toxicity and explored its potential mechanism.</p> <p>Methods</p> <p>Mice received an intracerebroventricular fusion of Aβ<sub>25-35</sub>. Pinocembrin was administrated orally at 20 mg/kg/day and 40 mg/kg/day for 8 days. Behavioral performance, cerebral cortex neuropil ultrastructure, neuronal degeneration and RAGE expression were assessed. Further, a RAGE-overexpressing cell model and an AD cell model were used for investigating the mechanisms of pinocembrin. The mechanisms underlying the efficacy of pinocembrin were conducted on target action, mitochondrial function and potential signal transduction using fluorescence-based multiparametric technologies on a high-content analysis platform.</p> <p>Results</p> <p>Our results showed that oral administration of pinocembrin improved cognitive function, preserved the ultrastructural neuropil and decreased neurodegeneration of the cerebral cortex in Aβ<sub>25-35</sub>-treated mice. Pinocembrin did not have a significant effect on inhibiting Aβ<sub>1-42 </sub>production and scavenging intracellular reactive oxygen species (ROS). However, pinocembrin significantly inhibited the upregulation of RAGE transcripts and protein expression both <it>in vivo </it>and <it>in vitro</it>, and also markedly depressed the activation of p38 mitogen-activated protein kinase (MAPK)-MAPKAP kinase-2 (MK2)-heat shock protein 27 (HSP27) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK)-c-Jun pathways and the downstream nuclear factor κB (NFκB) inflammatory response subsequent to Aβ-RAGE interaction. In addition, pinocembrin significantly alleviated mitochondrial dysfunction through improving mitochondrial membrane potential and inhibiting mitochondrial oxidative stress, and regulated mitochondrion-mediated apoptosis by restoration of B cell lymphoma 2 (Bcl-2) and cytochrome <it>c </it>and inactivation of caspase 3 and caspase 9.</p> <p>Conclusions</p> <p>Pinocembrin was shown to infer cognitive improvement and neuronal protection in AD models. The mechanisms of action of the compound were illustrated on RAGE-dependent transduction inhibition and mitochondrion protection. It appears to be a promising candidate for the prevention and therapy of AD.</p> |
| first_indexed | 2024-04-13T10:13:08Z |
| format | Article |
| id | doaj.art-8663fe71aba440948b13d819f4bf56f6 |
| institution | Directory Open Access Journal |
| issn | 1741-7015 |
| language | English |
| last_indexed | 2024-04-13T10:13:08Z |
| publishDate | 2012-09-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medicine |
| spelling | doaj.art-8663fe71aba440948b13d819f4bf56f62022-12-22T02:50:51ZengBMCBMC Medicine1741-70152012-09-0110110510.1186/1741-7015-10-105Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosisLiu RuiWu Cai-xiaZhou DanYang FanTian ShuoZhang LiZhang Tian-taiDu Guan-hua<p>Abstract</p> <p>Background</p> <p>It is known that amyloid-β peptide (Aβ) plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). Interaction between Aβ and the receptor for advanced glycation end products (RAGE) has been implicated in neuronal degeneration associated with this disease. Pinocembrin, a flavonoid abundant in propolis, has been reported to possess numerous biological activities beneficial to health. Our previous studies have demonstrated that pinocembrin has neuroprotective effects on ischemic and vascular dementia in animal models. It has been approved by the State Food and Drug Administration of China for clinical use in stroke patients. Against this background, we investigated the effects of pinocembrin on cognitive function and neuronal protection against Aβ-induced toxicity and explored its potential mechanism.</p> <p>Methods</p> <p>Mice received an intracerebroventricular fusion of Aβ<sub>25-35</sub>. Pinocembrin was administrated orally at 20 mg/kg/day and 40 mg/kg/day for 8 days. Behavioral performance, cerebral cortex neuropil ultrastructure, neuronal degeneration and RAGE expression were assessed. Further, a RAGE-overexpressing cell model and an AD cell model were used for investigating the mechanisms of pinocembrin. The mechanisms underlying the efficacy of pinocembrin were conducted on target action, mitochondrial function and potential signal transduction using fluorescence-based multiparametric technologies on a high-content analysis platform.</p> <p>Results</p> <p>Our results showed that oral administration of pinocembrin improved cognitive function, preserved the ultrastructural neuropil and decreased neurodegeneration of the cerebral cortex in Aβ<sub>25-35</sub>-treated mice. Pinocembrin did not have a significant effect on inhibiting Aβ<sub>1-42 </sub>production and scavenging intracellular reactive oxygen species (ROS). However, pinocembrin significantly inhibited the upregulation of RAGE transcripts and protein expression both <it>in vivo </it>and <it>in vitro</it>, and also markedly depressed the activation of p38 mitogen-activated protein kinase (MAPK)-MAPKAP kinase-2 (MK2)-heat shock protein 27 (HSP27) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK)-c-Jun pathways and the downstream nuclear factor κB (NFκB) inflammatory response subsequent to Aβ-RAGE interaction. In addition, pinocembrin significantly alleviated mitochondrial dysfunction through improving mitochondrial membrane potential and inhibiting mitochondrial oxidative stress, and regulated mitochondrion-mediated apoptosis by restoration of B cell lymphoma 2 (Bcl-2) and cytochrome <it>c </it>and inactivation of caspase 3 and caspase 9.</p> <p>Conclusions</p> <p>Pinocembrin was shown to infer cognitive improvement and neuronal protection in AD models. The mechanisms of action of the compound were illustrated on RAGE-dependent transduction inhibition and mitochondrion protection. It appears to be a promising candidate for the prevention and therapy of AD.</p>http://www.biomedcentral.com/1741-7015/10/105Alzheimer's diseaseamyloid-β peptideapoptosispinocembrinreceptor for advanced glycation end products |
| spellingShingle | Liu Rui Wu Cai-xia Zhou Dan Yang Fan Tian Shuo Zhang Li Zhang Tian-tai Du Guan-hua Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis BMC Medicine Alzheimer's disease amyloid-β peptide apoptosis pinocembrin receptor for advanced glycation end products |
| title | Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis |
| title_full | Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis |
| title_fullStr | Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis |
| title_full_unstemmed | Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis |
| title_short | Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis |
| title_sort | pinocembrin protects against β amyloid induced toxicity in neurons through inhibiting receptor for advanced glycation end products rage independent signaling pathways and regulating mitochondrion mediated apoptosis |
| topic | Alzheimer's disease amyloid-β peptide apoptosis pinocembrin receptor for advanced glycation end products |
| url | http://www.biomedcentral.com/1741-7015/10/105 |
| work_keys_str_mv | AT liurui pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT wucaixia pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT zhoudan pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT yangfan pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT tianshuo pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT zhangli pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT zhangtiantai pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis AT duguanhua pinocembrinprotectsagainstbamyloidinducedtoxicityinneuronsthroughinhibitingreceptorforadvancedglycationendproductsrageindependentsignalingpathwaysandregulatingmitochondrionmediatedapoptosis |